2-(5-(4-(4-isopropoxyphenylsulfonyl)piperazin-1-yl)-2-(nicotinamido)phenoxy)acetic acid

ID: ALA3972788

PubChem CID: 134154521

Max Phase: Preclinical

Molecular Formula: C27H30N4O7S

Molecular Weight: 554.63

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)Oc1ccc(S(=O)(=O)N2CCN(c3ccc(NC(=O)c4cccnc4)c(OCC(=O)O)c3)CC2)cc1

Standard InChI:  InChI=1S/C27H30N4O7S/c1-19(2)38-22-6-8-23(9-7-22)39(35,36)31-14-12-30(13-15-31)21-5-10-24(25(16-21)37-18-26(32)33)29-27(34)20-4-3-11-28-17-20/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,29,34)(H,32,33)

Standard InChI Key:  WSFKXTJEXGHTGR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 42  0  0  0  0  0  0  0  0999 V2000
    8.1967  -16.3810    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6094  -17.0909    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.0178  -16.3785    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3734  -18.7335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3723  -19.5530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0803  -19.9620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7900  -19.5525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7872  -18.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0786  -18.3246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4908  -18.3187    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1999  -18.7268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9040  -18.3190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9051  -17.5015    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1960  -17.0934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4858  -17.5028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0801  -20.7791    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3723  -21.1876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3721  -22.0048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6643  -22.4132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0797  -22.4135    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3205  -17.5015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3165  -18.3177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0234  -18.7262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7321  -18.3176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7295  -17.4962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0220  -17.0913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4403  -18.7253    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1475  -18.3157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8557  -18.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1464  -17.4985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6643  -19.9610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9569  -19.5519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2489  -19.9599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9575  -18.7347    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5402  -19.5521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8326  -19.9595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8315  -20.7776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5439  -21.1866    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2485  -20.7768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  8 10  1  0
  6 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 13  2  1  0
  2 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 24 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
  5 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  2  0
 33 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3972788

    ---

Associated Targets(Human)

PTGDR Tclin Prostanoid DP receptor (1356 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGER1 Tclin Prostanoid EP1 receptor (1696 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGER2 Tclin Prostanoid EP2 receptor (1730 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGER3 Tclin Prostanoid EP3 receptor (1985 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGER4 Tclin Prostanoid EP4 receptor (2181 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGFR Tclin Prostanoid FP receptor (687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGIR Tclin Prostanoid IP receptor (1280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 554.63Molecular Weight (Monoisotopic): 554.1835AlogP: 3.10#Rotatable Bonds: 10
Polar Surface Area: 138.37Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.13CX Basic pKa: 3.74CX LogP: 1.93CX LogD: -0.83
Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.39Np Likeness Score: -1.91

References

1.  (2012)  Sulfonamide derivative having PGD2 receptor antagonistic activity, 

Source